Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prions | 22 | 2019 | 54 | 3.010 |
Why?
|
| Prion Diseases | 15 | 2023 | 35 | 2.620 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 11 | 2019 | 13 | 2.060 |
Why?
|
| PrPSc Proteins | 12 | 2021 | 22 | 1.800 |
Why?
|
| PrPC Proteins | 9 | 2021 | 13 | 1.800 |
Why?
|
| Plaque, Amyloid | 4 | 2019 | 61 | 1.710 |
Why?
|
| Alzheimer Disease | 8 | 2023 | 518 | 1.640 |
Why?
|
| Cognitive Dysfunction | 2 | 2023 | 157 | 1.070 |
Why?
|
| Frontotemporal Dementia | 1 | 2023 | 30 | 0.810 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 10 | 2010 | 25 | 0.790 |
Why?
|
| Parkinson Disease | 2 | 2023 | 151 | 0.740 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2407 | 0.690 |
Why?
|
| Mice, Transgenic | 14 | 2021 | 1583 | 0.670 |
Why?
|
| Benzodioxoles | 1 | 2019 | 14 | 0.650 |
Why?
|
| Pyrazoles | 1 | 2019 | 151 | 0.600 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 214 | 0.580 |
Why?
|
| Brain | 12 | 2012 | 2327 | 0.500 |
Why?
|
| Parahippocampal Gyrus | 1 | 2013 | 3 | 0.450 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 31 | 0.450 |
Why?
|
| Mice | 19 | 2021 | 11932 | 0.410 |
Why?
|
| Sirolimus | 1 | 2012 | 164 | 0.370 |
Why?
|
| Animals | 29 | 2021 | 27691 | 0.350 |
Why?
|
| Cytosol | 2 | 2010 | 193 | 0.350 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2010 | 97 | 0.330 |
Why?
|
| Prion Proteins | 6 | 2018 | 10 | 0.320 |
Why?
|
| Mutation, Missense | 1 | 2009 | 282 | 0.290 |
Why?
|
| Wasting Disease, Chronic | 2 | 2021 | 2 | 0.290 |
Why?
|
| Deer | 2 | 2021 | 5 | 0.290 |
Why?
|
| Zoonoses | 2 | 2021 | 27 | 0.280 |
Why?
|
| Phenotype | 9 | 2018 | 2471 | 0.280 |
Why?
|
| Clonidine | 5 | 1989 | 33 | 0.250 |
Why?
|
| Dementia | 4 | 2010 | 205 | 0.240 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2005 | 90 | 0.230 |
Why?
|
| Endopeptidase K | 2 | 2019 | 12 | 0.230 |
Why?
|
| Sclerosis | 1 | 2003 | 29 | 0.220 |
Why?
|
| Point Mutation | 2 | 2001 | 246 | 0.210 |
Why?
|
| Ataxia | 2 | 2009 | 42 | 0.210 |
Why?
|
| Gene Expression | 2 | 2006 | 1312 | 0.210 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2005 | 188 | 0.210 |
Why?
|
| Equipment Contamination | 1 | 2002 | 25 | 0.200 |
Why?
|
| Hippocampus | 2 | 2003 | 450 | 0.200 |
Why?
|
| Iatrogenic Disease | 1 | 2002 | 71 | 0.200 |
Why?
|
| Surgical Instruments | 1 | 2002 | 57 | 0.200 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2003 | 132 | 0.200 |
Why?
|
| Protein Precursors | 2 | 2000 | 140 | 0.200 |
Why?
|
| Amyloid | 2 | 2000 | 95 | 0.200 |
Why?
|
| Disease Progression | 4 | 2018 | 1485 | 0.170 |
Why?
|
| Neurosurgical Procedures | 1 | 2002 | 244 | 0.170 |
Why?
|
| Humans | 31 | 2023 | 90568 | 0.170 |
Why?
|
| Aged | 13 | 2023 | 19404 | 0.170 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 86 | 0.170 |
Why?
|
| Family Health | 1 | 2000 | 162 | 0.160 |
Why?
|
| Receptors, Opioid | 2 | 1989 | 23 | 0.150 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2020 | 267 | 0.150 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 65 | 0.150 |
Why?
|
| Genotype | 4 | 2010 | 1855 | 0.150 |
Why?
|
| Male | 21 | 2020 | 42931 | 0.140 |
Why?
|
| Cell Line, Tumor | 4 | 2008 | 2607 | 0.140 |
Why?
|
| Rats, Inbred SHR | 5 | 1989 | 33 | 0.140 |
Why?
|
| Rats, Inbred Strains | 5 | 1989 | 311 | 0.140 |
Why?
|
| Mutation | 7 | 2010 | 4184 | 0.130 |
Why?
|
| tau Proteins | 2 | 2011 | 78 | 0.130 |
Why?
|
| Biological Assay | 1 | 2016 | 81 | 0.130 |
Why?
|
| Inclusion Bodies | 2 | 2012 | 34 | 0.120 |
Why?
|
| Neuroblastoma | 3 | 2008 | 391 | 0.120 |
Why?
|
| Thalamus | 2 | 2010 | 134 | 0.120 |
Why?
|
| Endorphins | 3 | 1989 | 13 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2010 | 281 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2009 | 794 | 0.120 |
Why?
|
| Blood Pressure | 4 | 1987 | 906 | 0.120 |
Why?
|
| Fasciculation | 1 | 1994 | 1 | 0.120 |
Why?
|
| Abducens Nerve | 1 | 1994 | 14 | 0.110 |
Why?
|
| Lyme Disease | 1 | 1994 | 9 | 0.110 |
Why?
|
| Ophthalmoplegia | 1 | 1994 | 11 | 0.110 |
Why?
|
| Autophagy | 1 | 2016 | 160 | 0.110 |
Why?
|
| Female | 11 | 2019 | 46855 | 0.110 |
Why?
|
| Protein Conformation | 3 | 2010 | 898 | 0.110 |
Why?
|
| Spinal Curvatures | 1 | 2013 | 7 | 0.110 |
Why?
|
| Peptide Hydrolases | 2 | 2010 | 101 | 0.110 |
Why?
|
| Time Factors | 3 | 2012 | 5365 | 0.100 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2013 | 28 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2013 | 6812 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2013 | 64 | 0.100 |
Why?
|
| Neurofibrillary Tangles | 2 | 2011 | 46 | 0.100 |
Why?
|
| Base Sequence | 4 | 2005 | 2329 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 854 | 0.100 |
Why?
|
| Tunicamycin | 1 | 2012 | 13 | 0.100 |
Why?
|
| Biomarkers | 1 | 2019 | 1797 | 0.100 |
Why?
|
| Hypertension | 3 | 1987 | 746 | 0.100 |
Why?
|
| Random Allocation | 1 | 2012 | 327 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 1989 | 36 | 0.100 |
Why?
|
| Analgesia | 2 | 1989 | 58 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 300 | 0.090 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 44 | 0.090 |
Why?
|
| Kuru | 1 | 2010 | 3 | 0.090 |
Why?
|
| Insomnia, Fatal Familial | 1 | 2010 | 3 | 0.090 |
Why?
|
| Protein Folding | 2 | 2010 | 291 | 0.090 |
Why?
|
| Injections, Intraventricular | 2 | 2006 | 19 | 0.090 |
Why?
|
| Brain Stem | 1 | 2010 | 167 | 0.080 |
Why?
|
| Benzothiazoles | 1 | 2009 | 16 | 0.080 |
Why?
|
| Heart Rate | 3 | 1987 | 496 | 0.080 |
Why?
|
| Fungal Proteins | 1 | 2010 | 142 | 0.080 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1989 | 16 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 697 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 335 | 0.080 |
Why?
|
| Bradycardia | 1 | 1989 | 39 | 0.080 |
Why?
|
| Thiazoles | 1 | 2009 | 127 | 0.080 |
Why?
|
| Cerebellum | 1 | 2010 | 250 | 0.080 |
Why?
|
| Transfection | 2 | 2008 | 910 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2012 | 2033 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1987 | 16 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 1607 | 0.070 |
Why?
|
| Protein Binding | 2 | 2010 | 1500 | 0.070 |
Why?
|
| Leupeptins | 1 | 2006 | 22 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 531 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 53 | 0.070 |
Why?
|
| Rats | 7 | 1989 | 4059 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2006 | 117 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 1986 | 79 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 324 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1247 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 339 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 282 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 56 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2008 | 2364 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 49 | 0.060 |
Why?
|
| Neurons | 3 | 2018 | 1593 | 0.060 |
Why?
|
| Perfusion | 1 | 1986 | 255 | 0.060 |
Why?
|
| Species Specificity | 5 | 2011 | 690 | 0.060 |
Why?
|
| Protein Interaction Mapping | 1 | 2005 | 81 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 1998 | 3029 | 0.060 |
Why?
|
| Heterozygote | 1 | 2005 | 373 | 0.060 |
Why?
|
| Middle Aged | 8 | 2011 | 26327 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2005 | 205 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1882 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 1986 | 258 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 646 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 3273 | 0.060 |
Why?
|
| Tryptamines | 1 | 1983 | 1 | 0.060 |
Why?
|
| Histological Techniques | 1 | 1983 | 36 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2010 | 1382 | 0.050 |
Why?
|
| Catecholamines | 1 | 1983 | 92 | 0.050 |
Why?
|
| Risk Factors | 2 | 2011 | 5580 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 3486 | 0.050 |
Why?
|
| Prevalence | 1 | 2005 | 1251 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 1999 | 298 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2005 | 1873 | 0.050 |
Why?
|
| Image Enhancement | 1 | 1983 | 566 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 827 | 0.040 |
Why?
|
| Naloxone | 3 | 1989 | 68 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 54 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2000 | 102 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 1999 | 102 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1999 | 122 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 565 | 0.040 |
Why?
|
| Adult | 6 | 2011 | 26940 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 1998 | 13 | 0.040 |
Why?
|
| Genetic Markers | 1 | 1999 | 477 | 0.040 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1998 | 12 | 0.040 |
Why?
|
| Neuroglia | 1 | 2018 | 105 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1806 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 1997 | 64 | 0.040 |
Why?
|
| Myoclonus | 1 | 1997 | 16 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1998 | 135 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 1998 | 51 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 1192 | 0.030 |
Why?
|
| Hand | 1 | 1997 | 143 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 1998 | 256 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 759 | 0.030 |
Why?
|
| Jews | 1 | 1995 | 42 | 0.030 |
Why?
|
| Genetic Testing | 2 | 2010 | 544 | 0.030 |
Why?
|
| Pedigree | 1 | 1996 | 969 | 0.030 |
Why?
|
| Cricetinae | 3 | 1998 | 560 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 914 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 923 | 0.030 |
Why?
|
| Age of Onset | 2 | 2008 | 319 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2012 | 9 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 135 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1723 | 0.020 |
Why?
|
| Cardiovascular System | 2 | 1989 | 63 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1103 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 133 | 0.020 |
Why?
|
| Rats, Inbred WKY | 2 | 1987 | 32 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2011 | 69 | 0.020 |
Why?
|
| Glutamine | 1 | 2011 | 81 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 525 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 426 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2523 | 0.020 |
Why?
|
| DNA | 1 | 1995 | 1314 | 0.020 |
Why?
|
| Enkephalin, Leucine | 1 | 1989 | 6 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 997 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2011 | 130 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2011 | 168 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 1989 | 45 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 513 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2008 | 106 | 0.020 |
Why?
|
| Alanine | 1 | 2008 | 85 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 83 | 0.020 |
Why?
|
| Epitopes | 1 | 2008 | 254 | 0.020 |
Why?
|
| beta-Endorphin | 1 | 1987 | 11 | 0.020 |
Why?
|
| Yohimbine | 1 | 1987 | 7 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1989 | 365 | 0.020 |
Why?
|
| Prazosin | 1 | 1987 | 9 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2011 | 231 | 0.020 |
Why?
|
| Naltrexone | 1 | 1989 | 138 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1987 | 79 | 0.020 |
Why?
|
| Mesocricetus | 2 | 1998 | 105 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 694 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 806 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1986 | 238 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1986 | 106 | 0.020 |
Why?
|
| Tachyphylaxis | 1 | 1985 | 14 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 1999 | 624 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 1986 | 114 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 1985 | 64 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 3810 | 0.020 |
Why?
|
| Equipment Design | 1 | 1986 | 423 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 661 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1989 | 1935 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 1594 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1983 | 15 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1983 | 172 | 0.010 |
Why?
|
| Fluorescence | 1 | 1983 | 104 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 284 | 0.010 |
Why?
|
| Primates | 1 | 1983 | 155 | 0.010 |
Why?
|
| Apolipoprotein C-I | 1 | 1999 | 2 | 0.010 |
Why?
|
| Apolipoproteins C | 1 | 1999 | 5 | 0.010 |
Why?
|
| Lod Score | 1 | 1999 | 152 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1999 | 108 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 1999 | 130 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 6425 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1998 | 128 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1998 | 117 | 0.010 |
Why?
|
| Perceptual Disorders | 1 | 1997 | 12 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1998 | 85 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1998 | 118 | 0.010 |
Why?
|
| Protons | 1 | 1997 | 101 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 124 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1997 | 315 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1998 | 239 | 0.010 |
Why?
|
| Libya | 1 | 1995 | 3 | 0.010 |
Why?
|
| Life Tables | 1 | 1995 | 47 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 1995 | 59 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 177 | 0.010 |
Why?
|
| Transgenes | 1 | 1995 | 185 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 1995 | 123 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1995 | 200 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 355 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 2076 | 0.010 |
Why?
|
| Age Factors | 1 | 1995 | 1871 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1998 | 2342 | 0.000 |
Why?
|
| Adolescent | 1 | 1995 | 9353 | 0.000 |
Why?
|